Loading...
Back to narrative

ACI: Upcoming Financial Review Will Support Bullish Long Term Outlook

Renewable Energy And Sustainable Agriculture Will Unlock New Potential

ACI logo
ACI
AnalystConsensusTarget
Not Invested
Published 16 Jan 2025

Update shared on 11 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-26.9%
7D
-2.7%

Analysts have nudged their price target for Archean Chemical Industries slightly higher to reflect modest improvements in discount rate assumptions, along with sustained expectations for strong revenue growth, stable profit margins, and an attractive future P/E multiple, implying fair value of ₹654.43 per share.

What's in the News

  • Board meeting scheduled on November 14, 2025, at 16:30 IST to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing)
  • Limited Review Report from statutory auditors on standalone and consolidated unaudited financial results to be considered by the board in the upcoming meeting (company filing)
  • Unaudited financial results for the period ended September 30, 2025, are planned to be published in newspapers in line with SEBI LODR Regulation 47 requirements (company filing)

Valuation Changes

  • Discount Rate, edged down slightly from 13.47 percent to 13.44 percent, modestly increasing the present value of projected cash flows.
  • Revenue Growth, effectively unchanged at around 30.31 percent, indicating continued confidence in the medium term expansion trajectory.
  • Net Profit Margin, stable at approximately 26.75 percent, reflecting no material revision in expected profitability levels.
  • Future P/E, eased marginally from 17.84x to 17.83x, signaling a very small reduction in the valuation multiple embedded in the model.
  • Fair Value, maintained at ₹654.43 per share, as minor adjustments to assumptions offset each other in the overall valuation outcome.

Have other thoughts on Archean Chemical Industries?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.